Fonarow GC - Search Results

1

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF.

DeVore AD, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Lewis EF, Butler J, Piña IL, Heidenreich PA, Allen LA, Yancy CW, Cooper LB, Felker GM, Kaltenbach LA, McRae AT, Lanfear DE, Harrison RW, Kociol RD, Disch M, Ariely D, Miller JM, Granger CB, Hernandez AF. DeVore AD, et al. Among authors: fonarow gc. Am Heart J. 2020 Feb;220:41-50. doi: 10.1016/j.ahj.2019.09.012. Epub 2019 Oct 23. Am Heart J. 2020. PMID: 31770656 Clinical Trial.

2

Extended comparison of quality of life between stable heart failure patients and heart transplant recipients.

Walden JA, Stevenson LW, Dracup K, Hook JF, Moser DK, Hamilton M, Fonarow GC. Walden JA, et al. Among authors: fonarow gc. J Heart Lung Transplant. 1994 Nov-Dec;13(6):1109-18. J Heart Lung Transplant. 1994. PMID: 7865518

3

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.

Fonarow GC, Stevenson LW, Walden JA, Livingston NA, Steimle AE, Hamilton MA, Moriguchi J, Tillisch JH, Woo MA. Fonarow GC, et al. J Am Coll Cardiol. 1997 Sep;30(3):725-32. doi: 10.1016/s0735-1097(97)00208-8. J Am Coll Cardiol. 1997. PMID: 9283532 Free article.

4

Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.

Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A. Hamilton MA, et al. Among authors: fonarow gc. Am J Cardiol. 1998 Feb 15;81(4):443-7. doi: 10.1016/s0002-9149(97)00950-8. Am J Cardiol. 1998. PMID: 9485134 Clinical Trial.

5

Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure.

Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW. Lucas C, et al. Among authors: fonarow gc. Am Heart J. 2000 Dec;140(6):840-7. doi: 10.1067/mhj.2000.110933. Am Heart J. 2000. PMID: 11099986

6

Educational needs of patients with advanced heart failure and their caregivers.

Walden JA, Dracup K, Westlake C, Erickson V, Hamilton MA, Fonarow GC. Walden JA, et al. Among authors: fonarow gc. J Heart Lung Transplant. 2001 Jul;20(7):766-9. doi: 10.1016/s1053-2498(00)00239-4. J Heart Lung Transplant. 2001. PMID: 11448807

7

The relationship between obesity and mortality in patients with heart failure.

Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. Horwich TB, et al. Among authors: fonarow gc. J Am Coll Cardiol. 2001 Sep;38(3):789-95. doi: 10.1016/s0735-1097(01)01448-6. J Am Coll Cardiol. 2001. PMID: 11527635 Free article.

8

Beta-blocker therapy for heart failure: the standard of care.

Cesario DA, Fonarow GC. Cesario DA, et al. Among authors: fonarow gc. Rev Cardiovasc Med. 2002 Winter;3(1):14-21. Rev Cardiovasc Med. 2002. PMID: 12439350 Review.

9

The impact of obesity on survival in patients with heart failure.

Horwich TB, Fonarow GC. Horwich TB, et al. Among authors: fonarow gc. Heart Fail Monit. 2002;3(1):8-14. Heart Fail Monit. 2002. PMID: 12634883 Review.

10

B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.

Fonarow GC. Fonarow GC. Heart Fail Rev. 2003 Oct;8(4):321-5. doi: 10.1023/a:1026170228469. Heart Fail Rev. 2003. PMID: 14574051 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,775 results

Search Page

Filters